3M Company (MMM) Stock Price & How to Invest

3M Company is a Minnesota-based industrial manufacturer with a portfolio spanning tens of thousands of products across three reportable segments after its April 2024 spin-off of the health care business as Solventum. Safety and Industrial covers abrasives, adhesives, tapes, and personal safety equipment; Transportation and Electronics serves automotive, aerospace, and electronics customers with films, bonding, and display materials; and Consumer sells household brands including Post-it, Scotch, Command, and Filtrete. The company sells into industrial, commercial, and retail channels globally and leans heavily on a long history of materials-science research and patents.

The investment picture is one of a mature, slow-growth conglomerate in the middle of a reset. Organic sales have been roughly flat to slightly negative, so the story is less about top-line expansion and more about restoring operating margins, generating free cash flow, and working through large multi-year legal settlements tied to Combat Arms earplugs and PFAS chemicals. New management has emphasized operational discipline and portfolio focus, and the stock carries a long-standing dividend, which makes it a name that income-oriented and value-oriented investors tend to watch closely.

Organic sales have been roughly flat to slightly down, so a stagnant top line is a real constraint on the growth case. Large multi-year settlement payments tied to Combat Arms earplugs (about $6.0 billion through 2029) and separate PFAS liabilities continue to draw cash and cloud long-term balance-sheet flexibility. As a global industrial supplier, 3M is exposed to manufacturing input costs, tariffs, currency swings, and cyclical demand in autos, electronics, and consumer channels. The reset also depends heavily on management executing margin and portfolio actions. Any slowdown in end markets or fresh legal exposure could pressure both earnings and the dividend narrative.

17 analysts publish price targets on MMM, averaging $181.85 against a $176.28 price as of August 2026, or +3.2%. The published targets run from $120.00 to $219.00, a moderate spread, and the ratings split 9 buy, 6 hold, 3 sell. Over the last six months there have been 7 raises and 4 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full MMM forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on 3M Company. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Margin recovery and operational discipline. 3M reported adjusted operating margins near 23.8% in the first quarter of 2026, up year over year, as management pushed cost control and simplification. The most optimistic published target, $219.00, assumes this works close to its best case.

The case against. Organic sales have been roughly flat to slightly down, so a stagnant top line is a real constraint on the growth case. The most pessimistic target, $120.00, is roughly what MMM is worth if this bites instead.

Read the full bull and bear case on MMM, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see 3M Company's investor relations page or your broker.

• Revenue (TTM): ~$24 billion
• Q1 2026 revenue: ~$6.0 billion
• FY2026 adjusted EPS guidance: ~$8.50 to $8.70
• Adjusted operating margin: ~23.8%
• Market cap: ~$76 billion
• Trailing P/E: ~28
• Dividend yield: ~2%

As of June 2026, 3M traded around 28 times trailing earnings and roughly 17 times forward estimates, a spread that reflects expected margin-driven earnings gains against a nearly flat sales base. The company reaffirmed full-year 2026 adjusted EPS guidance of about $8.50 to $8.70 and organic sales growth near 3%. These are approximate figures drawn from reported results and third-party data and will change with each quarter.

These are the investment theses MMM naturally fits into. Each links to a full theme guide listing every other stock that belongs and the ETFs commonly used as a passive proxy.

Other names that sit close to MMM: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get MMM exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so MMM sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where MMM fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

3M is a cash-generative industrial franchise working through a post-spin-off, post-litigation reset, so the case rests on steady margins and dividends rather than rapid growth.

Whether MMM is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is MMM a buy or a sell?, and where the stock could go from here in the MMM stock forecast.

For income investors, whether MMM pays a dividend and how the payout looks is covered in does MMM pay a dividend? And to weigh MMM against a peer, read the full side-by-side comparisons: MMM vs BAC and MMM vs CAT.